Ameritas Investment Partners’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.22M | Buy |
37,344
+5,866
| +19% | +$527K | 0.1% | 206 |
|
|
2025
Q4 | $2.75M | Sell |
31,478
-1,769
| -5% | -$134K | 0.08% | 234 |
|
|
2025
Q3 | $1.9M | Sell |
33,247
-1,793
| -5% | -$103K | 0.06% | 345 |
|
|
2025
Q2 | $2.07M | Sell |
35,040
-7,068
| -17% | -$457K | 0.07% | 322 |
|
|
2025
Q1 | $3.08M | Sell |
42,108
-773
| -2% | -$63.9K | 0.11% | 177 |
|
|
2024
Q4 | $3.55M | Sell |
42,881
-397
| -0.9% | -$31.3K | 0.12% | 148 |
|
|
2024
Q3 | $3.1M | Sell |
43,278
-778
| -2% | -$54.9K | 0.1% | 193 |
|
|
2024
Q2 | $3.02M | Sell |
44,056
-1,516
| -3% | -$90.6K | 0.1% | 184 |
|
|
2024
Q1 | $2.44M | Hold |
45,572
| – | – | 0.08% | 262 |
|
|
2023
Q4 | $2.43M | Buy |
45,572
+7,439
| +20% | +$363K | 0.09% | 231 |
|
|
2023
Q3 | $1.89M | Buy |
38,133
+6,299
| +20% | +$352K | 0.08% | 281 |
|
|
2023
Q2 | $1.9M | Hold |
31,834
| – | – | 0.07% | 308 |
|
|
2023
Q1 | $1.8M | Sell |
31,834
-5,000
| -14% | -$321K | 0.07% | 318 |
|
|
2022
Q4 | $2.74M | Buy |
36,834
+222
| +0.6% | +$15.1K | 0.11% | 186 |
|
|
2022
Q3 | $2.18M | Buy |
36,612
+978
| +3% | +$58.9K | 0.1% | 206 |
|
|
2022
Q2 | $2M | Hold |
35,634
| – | – | 0.09% | 240 |
|
|
2022
Q1 | $2.63M | Hold |
35,634
| – | – | 0.09% | 226 |
|
|
2021
Q4 | $2.57M | Buy |
35,634
+392
| +1% | +$28.5K | 0.09% | 249 |
|
|
2021
Q3 | $2.7M | Buy |
35,242
+2,167
| +7% | +$174K | 0.1% | 206 |
|
|
2021
Q2 | $2.56M | Sell |
33,075
-350
| -1% | -$24.9K | 0.09% | 238 |
|
|
2021
Q1 | $2.1M | Hold |
33,425
| – | – | 0.08% | 275 |
|
|
2020
Q4 | $2.18M | Hold |
33,425
| – | – | 0.1% | 243 |
|
|
2020
Q3 | $1.66M | Sell |
33,425
-339
| -1% | -$17.5K | 0.07% | 278 |
|
|
2020
Q2 | $1.61M | Sell |
33,764
-6,796
| -17% | -$328K | 0.08% | 275 |
|
|
2020
Q1 | $1.72M | Buy |
40,560
+171
| +0.4% | +$8.45K | 0.1% | 209 |
|
|
2019
Q4 | $2.38M | Sell |
40,389
-1,441
| -3% | -$78.2K | 0.11% | 191 |
|
|
2019
Q3 | $2.14M | Sell |
41,830
-678
| -2% | -$32.3K | 0.1% | 217 |
|
|
2019
Q2 | $1.8M | Buy |
42,508
+415
| +1% | +$18K | 0.08% | 270 |
|
|
2019
Q1 | $2.08M | Hold |
42,093
| – | – | 0.1% | 223 |
|
|
2018
Q4 | $1.82M | Buy |
42,093
+643
| +2% | +$32.1K | 0.1% | 222 |
|
|
2018
Q3 | $2.35M | Sell |
41,450
-15,000
| -27% | -$789K | 0.11% | 202 |
|
|
2018
Q2 | $2.85M | Sell |
56,450
-7,500
| -12% | -$391K | 0.14% | 144 |
|
|
2018
Q1 | $3.19M | Sell |
63,950
-9,200
| -13% | -$432K | 0.15% | 125 |
|
|
2017
Q4 | $3.01M | Buy |
73,150
+496
| +0.7% | +$17.4K | 0.14% | 155 |
|
|
2017
Q3 | $2.17M | Hold |
72,654
| – | – | 0.1% | 214 |
|
|
2017
Q2 | $2.41M | Hold |
72,654
| – | – | 0.12% | 189 |
|
|
2017
Q1 | $2.15M | Sell |
72,654
-3,697
| -5% | -$101K | 0.11% | 212 |
|
|
2016
Q4 | $1.89M | Buy |
76,351
+28,051
| +58% | +$637K | 0.1% | 250 |
|
|
2016
Q3 | $1.09M | Hold |
48,300
| – | – | 0.06% | 440 |
|
|
2016
Q2 | $1.15M | Hold |
48,300
| – | – | 0.07% | 261 |
|
|
2016
Q1 | $1.15M | Hold |
48,300
| – | – | 0.08% | 257 |
|
|
2015
Q4 | $1.34M | Hold |
48,300
| – | – | 0.09% | 233 |
|
|
2015
Q3 | $997K | Buy |
+48,300
| New | +$1.22M | 0.07% | 278 |
|
Other funds holding GMED
VCM
VPM
SC
Ameritas Investment Partners's GMED Position: Q1 2026 in Review
Ameritas Investment Partners increased its Globus Medical (GMED) stake by 19% in Q1 2026, buying an estimated $527K and bringing the position to 37,344 shares worth $3.22M. The position accounts for 0.1% of the portfolio, ranked #206.
Ameritas Investment Partners first reported a position in GMED in Q3 2015 and has held it in 43 quarters since. The position peaked at $3.55M in Q4 2024. 603 funds tracked by Wall St. Rank hold GMED as of Q1 2026.
- Ameritas Investment Partners held 37,344 shares of Globus Medical worth $3.22M as of Q1 2026.
- Ameritas Investment Partners bought 5,866 Globus Medical shares in Q1 2026, an estimated $527K.
- Globus Medical made up 0.1% of Ameritas Investment Partners's portfolio in Q1 2026, its #206 holding.
- Ameritas Investment Partners first reported a position in Globus Medical in Q3 2015 and has held it in 43 quarters since.
- Ameritas Investment Partners's Globus Medical position peaked at $3.55M in Q4 2024.
- 603 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.
Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.